ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)

NCT04561518 · clinicaltrials.gov ↗
RECRUITING
Status
1500
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Alnylam Pharmaceuticals